CR20170331A - Síntesis total de trioxacarcina dc-45-a2 y preparación de análogos de trioxacarcina - Google Patents
Síntesis total de trioxacarcina dc-45-a2 y preparación de análogos de trioxacarcinaInfo
- Publication number
- CR20170331A CR20170331A CR20170331A CR20170331A CR20170331A CR 20170331 A CR20170331 A CR 20170331A CR 20170331 A CR20170331 A CR 20170331A CR 20170331 A CR20170331 A CR 20170331A CR 20170331 A CR20170331 A CR 20170331A
- Authority
- CR
- Costa Rica
- Prior art keywords
- trioxacarcine
- analogs
- preparation
- total synthesis
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
Abstract
En un aspecto, la presente invención proporciona derivados novedosos de análogos de trioxacarina de la fórmula (I) en donde las variables son como se define anteriormente. La aplicación también proporciona composiciones, métodos de tratamiento, y métodos de síntesis de los mismos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094662P | 2014-12-19 | 2014-12-19 | |
| US201562186128P | 2015-06-29 | 2015-06-29 | |
| PCT/US2015/066703 WO2016100833A2 (en) | 2014-12-19 | 2015-12-18 | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20170331A true CR20170331A (es) | 2017-11-17 |
Family
ID=56127867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20170331A CR20170331A (es) | 2014-12-19 | 2015-12-18 | Síntesis total de trioxacarcina dc-45-a2 y preparación de análogos de trioxacarcina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10899773B2 (es) |
| EP (1) | EP3233877A4 (es) |
| JP (1) | JP2017537968A (es) |
| KR (1) | KR20170122718A (es) |
| CN (1) | CN107250144A (es) |
| AU (1) | AU2015364347A1 (es) |
| BR (1) | BR112017013194A2 (es) |
| CA (1) | CA2970955A1 (es) |
| CL (1) | CL2017001599A1 (es) |
| CO (1) | CO2017007074A2 (es) |
| CR (1) | CR20170331A (es) |
| DO (1) | DOP2017000144A (es) |
| EA (1) | EA201791388A1 (es) |
| EC (1) | ECSP17046657A (es) |
| GT (1) | GT201700139A (es) |
| HK (1) | HK1243422A1 (es) |
| IL (1) | IL252947A0 (es) |
| MA (1) | MA41216A (es) |
| MX (1) | MX2017008162A (es) |
| PE (1) | PE20171787A1 (es) |
| PH (1) | PH12017501147A1 (es) |
| SG (1) | SG11201704935XA (es) |
| WO (1) | WO2016100833A2 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019036537A1 (en) * | 2017-08-17 | 2019-02-21 | William Marsh Rice University | ANALOGUES AND DIMER OF TRIOXACARCIN AS POWERFUL ANTICANCER AGENTS |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5815995A (ja) | 1981-07-22 | 1983-01-29 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５−ａ↓１およびｄｃ−４５−ａ↓２ならびにそれらの製造法 |
| EP0157203A3 (en) | 1984-04-04 | 1986-10-01 | American Cyanamid Company | Antitumor agents ll-d49194 alpha 1, ll-d49194 beta, ll-d49194 beta 2, ll-d49194 upsilon, ll-d49194 delta, ll-d49194 epsilon, ll-d49194 zeta, and ll-d49194 eta |
| JPS63135389A (ja) | 1986-11-26 | 1988-06-07 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５類の誘導体 |
| WO2011119549A1 (en) | 2010-03-22 | 2011-09-29 | President And Fellows Of Harvard College | Trioxacarcins and uses thereof |
| WO2014082065A1 (en) | 2012-11-26 | 2014-05-30 | President And Fellows Of Harvard College | Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof |
-
2015
- 2015-12-17 MA MA041216A patent/MA41216A/fr unknown
- 2015-12-18 US US15/537,319 patent/US10899773B2/en active Active
- 2015-12-18 KR KR1020177020092A patent/KR20170122718A/ko unknown
- 2015-12-18 SG SG11201704935XA patent/SG11201704935XA/en unknown
- 2015-12-18 CR CR20170331A patent/CR20170331A/es unknown
- 2015-12-18 CA CA2970955A patent/CA2970955A1/en not_active Abandoned
- 2015-12-18 EA EA201791388A patent/EA201791388A1/ru unknown
- 2015-12-18 MX MX2017008162A patent/MX2017008162A/es unknown
- 2015-12-18 EP EP15871176.2A patent/EP3233877A4/en not_active Withdrawn
- 2015-12-18 JP JP2017532666A patent/JP2017537968A/ja not_active Withdrawn
- 2015-12-18 PE PE2017001101A patent/PE20171787A1/es unknown
- 2015-12-18 AU AU2015364347A patent/AU2015364347A1/en not_active Abandoned
- 2015-12-18 BR BR112017013194-3A patent/BR112017013194A2/pt not_active Application Discontinuation
- 2015-12-18 WO PCT/US2015/066703 patent/WO2016100833A2/en active Application Filing
- 2015-12-18 CN CN201580076346.2A patent/CN107250144A/zh active Pending
-
2017
- 2017-06-15 IL IL252947A patent/IL252947A0/en unknown
- 2017-06-19 CL CL2017001599A patent/CL2017001599A1/es unknown
- 2017-06-19 PH PH12017501147A patent/PH12017501147A1/en unknown
- 2017-06-19 DO DO2017000144A patent/DOP2017000144A/es unknown
- 2017-06-19 GT GT201700139A patent/GT201700139A/es unknown
- 2017-07-14 CO CONC2017/0007074A patent/CO2017007074A2/es unknown
- 2017-07-19 EC ECIEPI201746657A patent/ECSP17046657A/es unknown
-
2018
- 2018-02-28 HK HK18102899.8A patent/HK1243422A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10899773B2 (en) | 2021-01-26 |
| MX2017008162A (es) | 2018-03-06 |
| EA201791388A1 (ru) | 2017-11-30 |
| CO2017007074A2 (es) | 2017-10-20 |
| US20190023717A1 (en) | 2019-01-24 |
| HK1243422A1 (zh) | 2018-07-13 |
| AU2015364347A1 (en) | 2017-07-13 |
| SG11201704935XA (en) | 2017-07-28 |
| WO2016100833A2 (en) | 2016-06-23 |
| MA41216A (fr) | 2017-10-24 |
| CA2970955A1 (en) | 2016-06-23 |
| PE20171787A1 (es) | 2017-12-28 |
| KR20170122718A (ko) | 2017-11-06 |
| ECSP17046657A (es) | 2019-03-29 |
| EP3233877A4 (en) | 2018-10-17 |
| EP3233877A2 (en) | 2017-10-25 |
| CL2017001599A1 (es) | 2018-11-09 |
| CN107250144A (zh) | 2017-10-13 |
| GT201700139A (es) | 2018-10-24 |
| PH12017501147A1 (en) | 2018-03-05 |
| DOP2017000144A (es) | 2017-09-29 |
| BR112017013194A2 (pt) | 2018-01-02 |
| WO2016100833A3 (en) | 2017-01-05 |
| JP2017537968A (ja) | 2017-12-21 |
| IL252947A0 (en) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20170573A (es) | Lactamas bicíclicas y métodos de uso de las mismas | |
| BR112017012272A2 (pt) | derivados de 2-anilinopirimidina como moduladores de egfr | |
| EA201691272A1 (ru) | Тетрагидропиридопиразины в качестве модуляторов gpr6 | |
| UY36705A (es) | Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj | |
| CO7400867A2 (es) | Modificador del sabor dulce | |
| TR201906366T4 (tr) | Polisiklik-karbamoilpiridon bileşiklerinin sentezi. | |
| NI201400079A (es) | Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CR20170008A (es) | Compuestos de [1,2,4] triazol e imidazol sustituidos | |
| EA201692526A1 (ru) | Замещенные [1,2,4]триазольные соединения | |
| GT201700190A (es) | Desacetoxitubulisina h y análogos de esta | |
| EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
| MA38982A1 (fr) | Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl | |
| SV2017005381A (es) | Compuestos de imidazopiridazina | |
| CO2017003004A2 (es) | Nuevas triazolo[4,5-d]pirimidinas | |
| EA201591451A1 (ru) | Модуляторы flap | |
| EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
| UY36070A (es) | Triterpenoides con actividad inhibidora de la maduración de hiv | |
| UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| GT201600232A (es) | Derivados de diheterociclo enlazado a cicloalquilo | |
| DOP2016000211A (es) | Pirazinas moduladoras de gpr6 | |
| CO2017009989A2 (es) | Piridopirimidinonas y utilización de las mismas como moduladores de receptores de nmda | |
| EA201690294A1 (ru) | Новые соединения и их применение для получения tau-визуализирующих агентов и tau-визуализирующих составов | |
| CO2017007074A2 (es) | Sintesis total de trioxacarcina dc-45-a2 y preparación de analogos de trioxacarcina | |
| EA201591449A1 (ru) | Способы получения противораковых композиций |